• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by MetLife Inc.

    1/9/26 4:44:04 PM ET
    $MET
    Life Insurance
    Finance
    Get the next $MET alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0000728618
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    METLIFE INC
    SEC File Number
    001-15787
    Address of Issuer
    200 Park Avenue
    New York
    NEW YORK
    10016
    Phone
    212-578-2211
    Name of Person for Whose Account the Securities are To Be Sold
    MetLife Separate Account SPI
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Affiliate

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common Stock
    Bernstein Institutional Services LLC
    245 Park Ave
    New York � NY � 10167
    56244836.3665889165601/09/2026
    N Y S E


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common Stock05/29/2015PurchaseGOLDMAN SACHSCheckbox not checked56206/03/2015Cash

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    MetLife 401k Plan Russell 1000 Value
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock10/29/202519615350.72
    Separate Account 149
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock11/20/2025302217.6
    Separate Account SPI
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock12/01/202533525563.85
    Separate Account II
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock12/17/202523119064.43
    Separate Account 149
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock12/19/202510815.7
    Separate Account II
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock12/19/2025383099.66
    Separate Account SPI
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock12/19/202513711175.09
    MetLife 401k Plan Russell 1000 Value
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock12/19/2025685546.76
    MetLife 401k Plan Trust-Large Cap Equity Index
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock12/19/202535929283.63

    144: Remarks and Signature

    Remarks
    Date of Notice
    01/09/2026

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    Mirsad Usejnoski

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $MET alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MET

    DatePrice TargetRatingAnalyst
    1/6/2026$97.00Outperform → In-line
    Evercore ISI
    12/16/2025$101.00Outperform
    Mizuho
    9/19/2025$84.00Overweight → Neutral
    Piper Sandler
    9/16/2025$95.00Outperform
    Wolfe Research
    1/23/2025$97.00Market Perform
    BMO Capital Markets
    10/9/2024$97.00Buy
    TD Cowen
    9/5/2024$91.00Overweight
    Barclays
    1/8/2024$80.00Neutral → Buy
    Goldman
    More analyst ratings

    $MET
    SEC Filings

    View All

    MetLife Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - METLIFE INC (0001099219) (Filer)

    3/5/26 4:24:21 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form 8-K filed by MetLife Inc.

    8-K - METLIFE INC (0001099219) (Filer)

    2/26/26 4:12:16 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form FWP filed by MetLife Inc.

    FWP - METLIFE INC (0001099219) (Subject)

    2/24/26 4:46:23 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by Glaser Daniel S

    4/A - METLIFE INC (0001099219) (Issuer)

    3/19/26 2:04:01 PM ET
    $MET
    Life Insurance
    Finance

    Amendment: SEC Form 3 filed by new insider Glaser Daniel S

    3/A - METLIFE INC (0001099219) (Issuer)

    3/19/26 2:02:36 PM ET
    $MET
    Life Insurance
    Finance

    Director Mckenzie Diana was granted 189 shares, increasing direct ownership by 0.80% to 23,751 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    3/12/26 4:08:00 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MetLife downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded MetLife from Outperform to In-line and set a new price target of $97.00

    1/6/26 8:46:59 AM ET
    $MET
    Life Insurance
    Finance

    Mizuho initiated coverage on MetLife with a new price target

    Mizuho initiated coverage of MetLife with a rating of Outperform and set a new price target of $101.00

    12/16/25 8:59:16 AM ET
    $MET
    Life Insurance
    Finance

    MetLife downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded MetLife from Overweight to Neutral and set a new price target of $84.00

    9/19/25 8:25:43 AM ET
    $MET
    Life Insurance
    Finance

    $MET
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Johnson Jeh C. bought $879 worth of shares (17 units at $51.69) and was granted 19 shares, increasing direct ownership by 1% to 2,545 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    12/18/23 5:20:05 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MetLife Study Finds AI Acceleration Is Creating New Concerns in Today's Workplace

    Research from leading benefits provider finds 61% of employees are concerned about the risks of AI—raising the stakes for clarity, skill support and benefits as work evolves As the adoption of artificial intelligence (AI) in the workplace accelerates, MetLife's 24th Annual U.S. Employee Benefit Trends Study (EBTS) reveals, alongside other findings, a workforce both optimistic about the technology's efficiency gains and concerned about how technological change is reshaping work, well‑being and long‑term security. MetLife's 2026 EBTS, released today, shows that AI is already deeply embedded in everyday work: 80% of employers say AI tools are part of everyday tasks and 83% say AI is helpin

    3/16/26 9:00:00 AM ET
    $MET
    Life Insurance
    Finance

    MetLife Recommends Shareholders Reject "Mini-Tender" Offer by Potemkin Limited

    MetLife, Inc. (NYSE:MET) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited ("Potemkin") to purchase up to 10,000 shares of MetLife, Inc. common stock from MetLife shareholders. The offer is for approximately 0.002 percent of MetLife shares of common stock outstanding as of February 12, 2026. Potemkin's offer price of $51.60 per share is approximately 27.09 percent lower than the $70.77 closing price of MetLife common stock on March 9, 2026. MetLife does not endorse Potemkin's unsolicited mini-tender offer and recommends that shareholders do not tender their shares in response to Potemkin's offer because the offer is at a price that is sign

    3/10/26 9:00:00 AM ET
    $MET
    Life Insurance
    Finance

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    $MET
    Financials

    Live finance-specific insights

    View All

    MetLife Confirms First Quarter 2026 Series A Preferred Stock Dividend

    MetLife, Inc. (NYSE:MET) today announced that it has confirmed its previously announced declaration of the first quarter 2026 dividend of $0.31501229 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). The New York Stock Exchange has not yet set an ex-dividend date for the Series A preferred stock. Following this confirmatory announcement, the New York Stock Exchange will set an ex-dividend date for the Series A preferred stock. The dividend will be payable March 16, 2026, to shareholders of record as of Friday, Feb. 27, 2026, due to the record date occurring on Sunday, March 1, 2026. About MetLife

    3/5/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Announces First Quarter 2026 Preferred Stock Dividend Actions

    Declares Series D, E and F Preferred Stock Dividends Declares Series A Preferred Stock Dividend, Subject to Final Confirmation MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of wh

    2/17/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Announces Full Year and 4Q 2025 Results

    MetLife, Inc. (NYSE:MET) today announced its full year and fourth quarter 2025 results. Earnings   Return   Per Share on Equity (ROE     4Q 2025   4Q 2025 Net Income $1.17 ROE 12.0%   Adjusted Earnings $2.49 Adjusted ROE 17.6% Full Year Results Net income was $3.2 billion, or $4.71 per share. Adjusted earnings per share, excluding total notable items, up 10%1 to $8.89. Premiums, fees and other revenues (PFOs) increased 10% to $57.6 billion. Adjusted PFOs, excluding pension risk transfers (PRT), were up 5% to $49.8 billion. RIS record sales,

    2/4/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Leadership Updates

    Live Leadership Updates

    View All

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    MetLife Appoints Two Experienced Leaders to Board of Directors

    MetLife, Inc. (NYSE:MET) today announced that Dan Glaser and Michelle Seitz were elected to its Board of Directors (the "Board"), effective immediately. Both leaders bring significant leadership and business experience to their roles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224365562/en/MetLife today announced that Dan Glaser and Michelle Seitz were elected to its Board of Directors, effective immediately. Glaser, currently an operating partner at the private investment firm CD&R, has held senior positions in commercial insurance and insurance brokerage for more than 40 years, including serving for a decade as presiden

    2/24/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Investment Management Completes Acquisition of PineBridge Investments

    The combination brings together global scale and deep specialization, accelerating MetLife's growth in asset management MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), closed today on its acquisition of PineBridge Investments (PineBridge). The combined business manages $734.7 billion1 of assets, serving clients around the world. Accelerating growth in asset management is a top priority for MetLife in its New Frontier strategy. The acquisition brings together MIM's institutional strength and scale with PineBridge's global footprint and deep specialization to position MIM as a top-tier diversified global asset manager. "Toget

    12/30/25 5:15:00 AM ET
    $MET
    Life Insurance
    Finance

    $MET
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    11/1/24 5:05:26 PM ET
    $MET
    Life Insurance
    Finance

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    8/1/24 4:38:49 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form SC 13D/A filed by MetLife Inc. (Amendment)

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    5/2/24 5:34:57 PM ET
    $MET
    Life Insurance
    Finance